Company Filing History:
Years Active: 2019
Title: Sandra Rost - Innovator in Cancer Treatment
Introduction
Sandra Rost is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on utilizing cancer biomarkers to improve patient outcomes.
Latest Patents
Sandra Rost holds a patent titled "Cancer treatment with c-met antagonists and correlation of the latter with HGF expression." This invention addresses cancer biomarkers, particularly highlighting HGF as a crucial biomarker for patient selection and prognosis in cancer. The patent also encompasses methods of therapeutic treatment, articles of manufacture, diagnostic kits, and methods for detection related to cancer treatment.
Career Highlights
Sandra is currently employed at Genentech, Inc., where she continues to advance her research in cancer therapies. Her dedication to improving cancer treatment options has positioned her as a key figure in the field.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Wei Yu and David Shames. These partnerships have further enhanced her research and contributed to the development of innovative cancer treatments.
Conclusion
Sandra Rost's work in cancer treatment exemplifies the impact of innovation in healthcare. Her contributions through patents and collaborations continue to pave the way for advancements in cancer therapies.